Skip to main content
Erschienen in: Quality of Life Research 1/2019

30.08.2018

The prognostic value of health-related quality of life in patients with Chagas heart disease

verfasst von: Henrique Silveira Costa, Márcia Maria Oliveira Lima, Pedro Henrique Scheidt Figueiredo, Ana Thereza Chaves, Maria Carmo Pereira Nunes, Manoel Otávio da Costa Rocha

Erschienen in: Quality of Life Research | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To verify the prognostic value of health-related quality of life (HRQoL) and the differences in HRQoL and clinical variables between groups of Chagas heart disease (CHD) patients with and without cardiovascular adverse events.

Methods

Seventy-five CHD patients were evaluated by echocardiography, maximal exercise testing, and Short-form of Health Survey (SF-36) Questionnaire. Patients were followed during 6 years. In the statistical analysis, uni- and multivariate Cox regression were performed to verify the accuracy of the HRQoL in predicting cardiovascular events.

Results

After the follow-up period (41 ± 12 months), 20 patients (27%) had adverse events. Those with poor outcome had lower left ventricular ejection fraction (LVEF) (p = 0.002), higher left ventricular end-diastolic diameter (LVDd) (p = 0.019), and worse scores in general health perceptions (p = 0.047), social role functioning (p = 0.026), and mental component summary (p = 0.043) of SF-36. Patients with lower LVEF (p = 0.003), higher LVDd (p = 0.022), worse HRQoL in the general heath perceptions domain (p = 0.022), and mental component summary (p = 0.031) were associated with worse prognosis. In the multivariate Cox regression, LVEF (HR 0.94, 95% CI from 0.90 to 0.98, p = 0.007) and mental component summary (HR 0.98, 95% CI from 0.94 to 1.00, p = 0.047) remained as independent predictors of adverse events in CHD patients.

Conclusion

The assessment of HRQoL, especially the mental component, should be taken into account to provide an accurate prognosis in addition to other well-established predictors of poor outcomes in CHD patients.
Literatur
2.
Zurück zum Zitat Nunes, M. C., Dones, W., Morillo, C. A., Encina, J. J., & Ribeiro, A. L., Council on Chagas Disease of the Interamerican Society of Cardiology (2013). Chagas disease: An overview of clinical and epidemiological aspects. Journal of the American College of Cardiology, 62(9), 767–776.CrossRefPubMed Nunes, M. C., Dones, W., Morillo, C. A., Encina, J. J., & Ribeiro, A. L., Council on Chagas Disease of the Interamerican Society of Cardiology (2013). Chagas disease: An overview of clinical and epidemiological aspects. Journal of the American College of Cardiology, 62(9), 767–776.CrossRefPubMed
3.
Zurück zum Zitat Chagas, C. (1909). Nova tripanozomiaze humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Memórias do Instituto Oswaldo Cruz, 1(2), 159–218.CrossRef Chagas, C. (1909). Nova tripanozomiaze humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Memórias do Instituto Oswaldo Cruz, 1(2), 159–218.CrossRef
4.
Zurück zum Zitat Andrade, J. P., Marin Neto, J. A., Paola, A. A., Vilas-Boas, F., Oliveira, G. M., Bacal, F., et al. (2011). I Latin American guidelines for the diagnosis and treatment of Chagas’ heart disease: Executive summary. Arquivos Brasileiros de Cardiologia, 96(6), 434–442.CrossRefPubMed Andrade, J. P., Marin Neto, J. A., Paola, A. A., Vilas-Boas, F., Oliveira, G. M., Bacal, F., et al. (2011). I Latin American guidelines for the diagnosis and treatment of Chagas’ heart disease: Executive summary. Arquivos Brasileiros de Cardiologia, 96(6), 434–442.CrossRefPubMed
5.
Zurück zum Zitat Dias, J. C. P., Ramos, A. N. Jr., Gontijo, E. D., Luquetti, A., Shikanai-Yasuda, M. A., Coura, J. R., et al. (2016). II Consenso Brasileiro em Doença de Chagas, 2015. Epidemiologia e Serviços de Saúde, 25, 7–86.PubMed Dias, J. C. P., Ramos, A. N. Jr., Gontijo, E. D., Luquetti, A., Shikanai-Yasuda, M. A., Coura, J. R., et al. (2016). II Consenso Brasileiro em Doença de Chagas, 2015. Epidemiologia e Serviços de Saúde, 25, 7–86.PubMed
6.
Zurück zum Zitat Hotez, P. J., Dumonteil, E., Betancourt Cravioto, M., Bottazzi, M. E., Tapia-Conyer, R., Meymandi, S., et al. (2013). An unfolding tragedy of Chagas disease in North America. PLoS Neglected Tropical Diseases, 7(10), e2300.CrossRefPubMedPubMedCentral Hotez, P. J., Dumonteil, E., Betancourt Cravioto, M., Bottazzi, M. E., Tapia-Conyer, R., Meymandi, S., et al. (2013). An unfolding tragedy of Chagas disease in North America. PLoS Neglected Tropical Diseases, 7(10), e2300.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Requena-Mendez, A., Aldasoro, E., de Lazzari, E., Sicuri, E., Brown, M., Moore, D. A., et al. (2015). Prevalence of Chagas disease in Latin-American migrants living in Europe: A systematic review and meta-analysis. PLoS Neglected Tropical Diseases, 9(2), e0003540.CrossRefPubMedPubMedCentral Requena-Mendez, A., Aldasoro, E., de Lazzari, E., Sicuri, E., Brown, M., Moore, D. A., et al. (2015). Prevalence of Chagas disease in Latin-American migrants living in Europe: A systematic review and meta-analysis. PLoS Neglected Tropical Diseases, 9(2), e0003540.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Antinori, S., Galimberti, L., Bianco, R., Grande, R., Galli, M., & Corbellino, M. (2017). Chagas disease in Europe: A review for the internist in the globalized world. European Journal of Internal Medicine, 43, 6–15.CrossRefPubMed Antinori, S., Galimberti, L., Bianco, R., Grande, R., Galli, M., & Corbellino, M. (2017). Chagas disease in Europe: A review for the internist in the globalized world. European Journal of Internal Medicine, 43, 6–15.CrossRefPubMed
9.
Zurück zum Zitat Rocha, M. O., Teixeira, M. M., & Ribeiro, A. L. (2007). An update on the management of Chagas cardiomyopathy. Expert Review of Anti Infective Therapy, 5(4), 727–743.CrossRefPubMed Rocha, M. O., Teixeira, M. M., & Ribeiro, A. L. (2007). An update on the management of Chagas cardiomyopathy. Expert Review of Anti Infective Therapy, 5(4), 727–743.CrossRefPubMed
10.
Zurück zum Zitat Ribeiro, A. L., Nunes, M. P., Teixeira, M. M., & Rocha, M. O. (2012). Diagnosis and management of Chagas disease and cardiomyopathy. Nature Reviews Cardiology, 9(10), 576–589.CrossRefPubMed Ribeiro, A. L., Nunes, M. P., Teixeira, M. M., & Rocha, M. O. (2012). Diagnosis and management of Chagas disease and cardiomyopathy. Nature Reviews Cardiology, 9(10), 576–589.CrossRefPubMed
11.
Zurück zum Zitat Oliveira, B. G., Abreu, M. N., Abreu, C. D., Rocha, M. O., & Ribeiro, A. L. (2011). Health-related quality of life in patients with Chagas disease. The Journal of the Brazilian Society of Tropical Medicine, 44(2), 150–156.PubMed Oliveira, B. G., Abreu, M. N., Abreu, C. D., Rocha, M. O., & Ribeiro, A. L. (2011). Health-related quality of life in patients with Chagas disease. The Journal of the Brazilian Society of Tropical Medicine, 44(2), 150–156.PubMed
12.
Zurück zum Zitat Ozaki, Y., Guariento, M. E., & de Almeida, E. A. (2011). Quality of life and depressive symptoms in Chagas disease patients. Quality of Life Research, 20(1), 133–138.CrossRefPubMed Ozaki, Y., Guariento, M. E., & de Almeida, E. A. (2011). Quality of life and depressive symptoms in Chagas disease patients. Quality of Life Research, 20(1), 133–138.CrossRefPubMed
13.
Zurück zum Zitat Pelegrino, V. M., Dantas, R. A., Ciol, M. A., Clark, A. M., Rossi, L. A., & Simoes, M. V. (2011). Health-related quality of life in Brazilian outpatients with Chagas and non-Chagas cardiomyopathy. Heart and Lung, 40(3), e25–e31.CrossRefPubMed Pelegrino, V. M., Dantas, R. A., Ciol, M. A., Clark, A. M., Rossi, L. A., & Simoes, M. V. (2011). Health-related quality of life in Brazilian outpatients with Chagas and non-Chagas cardiomyopathy. Heart and Lung, 40(3), e25–e31.CrossRefPubMed
14.
Zurück zum Zitat Sousa, G. R., Costa, H. S., Souza, A. C., Nunes, M. C. P., Lima, M. M. O., & Rocha, M. O. C. (2015). Health-related quality of life in patients with Chagas disease: A review of the evidence. The Journal of the Brazilian Society of Tropical Medicine, 48(2), 121–128.PubMed Sousa, G. R., Costa, H. S., Souza, A. C., Nunes, M. C. P., Lima, M. M. O., & Rocha, M. O. C. (2015). Health-related quality of life in patients with Chagas disease: A review of the evidence. The Journal of the Brazilian Society of Tropical Medicine, 48(2), 121–128.PubMed
15.
Zurück zum Zitat The Criteria Committee of the New York Heart Association. (1994). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Boston, MA: Little, Brown & Co. The Criteria Committee of the New York Heart Association. (1994). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Boston, MA: Little, Brown & Co.
16.
Zurück zum Zitat Carson, P., Tam, S. W., Ghali, J. K., Archambault, W. T., Taylor, A., Cohn, J. N., et al. (2009). Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial. Journal of Cardiac Failure, 15(10), 835–842.CrossRefPubMed Carson, P., Tam, S. W., Ghali, J. K., Archambault, W. T., Taylor, A., Cohn, J. N., et al. (2009). Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial. Journal of Cardiac Failure, 15(10), 835–842.CrossRefPubMed
17.
Zurück zum Zitat Kato, N., Kinugawa, K., Seki, S., Shiga, T., Hatano, M., Yao, A., et al. (2011). Quality of life as an independent predictor for cardiac events and death in patients with heart failure. Circulation Journal, 75(7), 1661–1669.CrossRefPubMed Kato, N., Kinugawa, K., Seki, S., Shiga, T., Hatano, M., Yao, A., et al. (2011). Quality of life as an independent predictor for cardiac events and death in patients with heart failure. Circulation Journal, 75(7), 1661–1669.CrossRefPubMed
18.
Zurück zum Zitat Lupon, J., Gastelurrutia, P., de Antonio, M., Gonzalez, B., Cano, L., Cabanes, R., et al. (2013). Quality of life monitoring in ambulatory heart failure patients: Temporal changes and prognostic value. European Journal of Heart Failure, 15(1), 103–109.CrossRefPubMed Lupon, J., Gastelurrutia, P., de Antonio, M., Gonzalez, B., Cano, L., Cabanes, R., et al. (2013). Quality of life monitoring in ambulatory heart failure patients: Temporal changes and prognostic value. European Journal of Heart Failure, 15(1), 103–109.CrossRefPubMed
19.
Zurück zum Zitat Szygula-Jurkiewicz, B., Zakliczynski, M., Owczarek, A., Partyka, R., Moscinski, M., Pudlo, R., et al. (2014). Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure. Polish Journal of Cardio-Thoracic Surgery, 11(3), 283–288.CrossRefPubMed Szygula-Jurkiewicz, B., Zakliczynski, M., Owczarek, A., Partyka, R., Moscinski, M., Pudlo, R., et al. (2014). Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure. Polish Journal of Cardio-Thoracic Surgery, 11(3), 283–288.CrossRefPubMed
20.
Zurück zum Zitat Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., et al. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 28(1), 1–39 e14.CrossRefPubMed Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., et al. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 28(1), 1–39 e14.CrossRefPubMed
21.
Zurück zum Zitat Bruce, R., Kusumi, F., & Hosmer, D. (1973). Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. American Heart Journal, 85, 546–562.CrossRefPubMed Bruce, R., Kusumi, F., & Hosmer, D. (1973). Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. American Heart Journal, 85, 546–562.CrossRefPubMed
22.
Zurück zum Zitat ACSM. (2006). ACSM’s guidelines for exercise testing and exercise prescription (7th ed.). Philadelphia: Lippincott, Williams & Wilkins. ACSM. (2006). ACSM’s guidelines for exercise testing and exercise prescription (7th ed.). Philadelphia: Lippincott, Williams & Wilkins.
23.
Zurück zum Zitat Cole, C. R., Blackstone, E. H., Pashkow, F. J., Snader, C. E., & Lauer, M. S. (1999). Heart-rate recovery immediately after exercise as a predictor of mortality. New England Journal of Medicine, 341(18), 1351–1357.CrossRefPubMed Cole, C. R., Blackstone, E. H., Pashkow, F. J., Snader, C. E., & Lauer, M. S. (1999). Heart-rate recovery immediately after exercise as a predictor of mortality. New England Journal of Medicine, 341(18), 1351–1357.CrossRefPubMed
24.
Zurück zum Zitat Ciconelli, R. M., Ferraz, M. B., Santos, W., Meinão, I., & Quaresma, M. R. (1997). Translation to Brazilian Portuguese and validation of the generic questionnaire to assessment quality of life—the SF-36 (SF-36 Brazil). Revsta Brasileira de Reumatologia, 39, 143–150. Ciconelli, R. M., Ferraz, M. B., Santos, W., Meinão, I., & Quaresma, M. R. (1997). Translation to Brazilian Portuguese and validation of the generic questionnaire to assessment quality of life—the SF-36 (SF-36 Brazil). Revsta Brasileira de Reumatologia, 39, 143–150.
25.
Zurück zum Zitat Nunes, M. C. P., do Carmo, A. A. L., Rocha, M. O. C., & Ribeiro, A. L. (2012). Mortality prediction in Chagas heart disease. Expert Review of Cardiovascular Therapy, 10(9), 1173–1184.CrossRefPubMed Nunes, M. C. P., do Carmo, A. A. L., Rocha, M. O. C., & Ribeiro, A. L. (2012). Mortality prediction in Chagas heart disease. Expert Review of Cardiovascular Therapy, 10(9), 1173–1184.CrossRefPubMed
26.
Zurück zum Zitat Rassi, A. Jr., Rassi, A., & Rassi, S. G. (2007). Predictors of mortality in chronic Chagas disease: A systematic review of observational studies. Circulation, 115(9), 1101–1108.CrossRefPubMed Rassi, A. Jr., Rassi, A., & Rassi, S. G. (2007). Predictors of mortality in chronic Chagas disease: A systematic review of observational studies. Circulation, 115(9), 1101–1108.CrossRefPubMed
27.
Zurück zum Zitat Heidenreich, P. A., Spertus, J. A., Jones, P. G., Weintraub, W. S., Rumsfeld, J. S., Rathore, S. S., et al. (2006). Health status identifies heart failure outpatients at risk for hospitalization or death. Journal of the American College of Cardiology, 47(4), 752–756.CrossRefPubMed Heidenreich, P. A., Spertus, J. A., Jones, P. G., Weintraub, W. S., Rumsfeld, J. S., Rathore, S. S., et al. (2006). Health status identifies heart failure outpatients at risk for hospitalization or death. Journal of the American College of Cardiology, 47(4), 752–756.CrossRefPubMed
28.
Zurück zum Zitat Sullivan, M. D., Levy, W. C., Russo, J. E., Crane, B., & Spertus, J. A. (2007). Summary health status measures in advanced heart failure: Relationship to clinical variables and outcome. Journal of Cardiac Failure, 13(7), 560–568.CrossRefPubMed Sullivan, M. D., Levy, W. C., Russo, J. E., Crane, B., & Spertus, J. A. (2007). Summary health status measures in advanced heart failure: Relationship to clinical variables and outcome. Journal of Cardiac Failure, 13(7), 560–568.CrossRefPubMed
29.
Zurück zum Zitat Garin, O., Ferrer, M., Pont, A., Rue, M., Kotzeva, A., Wiklund, I., et al. (2009). Disease-specific health-related quality of life questionnaires for heart failure: A systematic review with meta-analyses. Quality of Life Research, 18(1), 71–85.CrossRefPubMed Garin, O., Ferrer, M., Pont, A., Rue, M., Kotzeva, A., Wiklund, I., et al. (2009). Disease-specific health-related quality of life questionnaires for heart failure: A systematic review with meta-analyses. Quality of Life Research, 18(1), 71–85.CrossRefPubMed
Metadaten
Titel
The prognostic value of health-related quality of life in patients with Chagas heart disease
verfasst von
Henrique Silveira Costa
Márcia Maria Oliveira Lima
Pedro Henrique Scheidt Figueiredo
Ana Thereza Chaves
Maria Carmo Pereira Nunes
Manoel Otávio da Costa Rocha
Publikationsdatum
30.08.2018
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 1/2019
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-1980-7

Weitere Artikel der Ausgabe 1/2019

Quality of Life Research 1/2019 Zur Ausgabe